Coating, coating forming method and medical instrument
By forming a graft polymer coating of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide on the surface of medical devices, the problem of insufficient antibacterial and anti-biological pollution ability of medical devices is solved, and the problem of insufficient anti-bacterial properties and anti-biological pollution ability of medical devices is achieved. Effective infection control of equipment such as urinary catheters reduces the risk of related infection.
Patent Information
- Application Number
- CN202310626607.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-30
- Publication Date
- 2024-12-03
AI Technical Summary
The antibacterial and anti-biological contamination ability of existing medical devices is poor, resulting in frequent medical device-related infections, especially serious catheter-related urinary tract infections. The existing antibacterial materials have bacterial resistance and cytotoxicity problems, so they cannot Effectively reduce the incidence of infection.
Using polydopamine coating, a graft polymer with carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide is formed on the surface of the substrate, and the oxidative autopolymerization and photopolymerization of dopamine are used to form antibacterial and The coating with anti-biological contamination characteristics combines chemical coupling of carboxymethyl chitosan quaternary ammonium salt to enhance the antibacterial properties of the coating.
The formed coating has good antibacterial and anti-biological contamination properties, can effectively reduce the incidence of medical device-related infections, is suitable for medical catheters, etc., and has a wide application range.
Smart Images

Figure CN119055845A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the medical field, and in particular to a coating, a method for forming the coating, and a medical device. Background Art
[0002] Hospital infection has become one of the leading causes of death and morbidity worldwide. Urinary tract infection accounts for about 40% of hospital-acquired infections and is an important factor causing hospital-acquired infections. Among them, urinary tract infections associated with indwelling catheters account for about 80%, which are called catheter-associated urinary tract infections (CAUTIs).
[0003] Medical device contamination, such as medical catheter-related contamination, is the most common. Taking catheter contamination as an example, once a catheter-related urinary tract infection occurs, the patient will be at risk of a series of serious complications. These complications include pyelonephritis, bacteremia, sepsis, catheter obstruction, stone formation, urethral stricture, urethritis, periurethral abscess, prostatitis, and infection with Candida and multidrug-resistant bacteria. In this process, the catheter provides a favorable place for bacterial colonization. Bacteria will form bacterial biofilms around them, which is also the reason for the high infection rate of catheter-related urinary tract infection. Once formed, bacterial biofilms can resist the human immune response and hinder the antibacterial effect of antibiotics, chemical bactericides and disinfectants on bacteria.
[0004] In order to prevent the formation of biofilm on the surface of medical devices, people have studied many new technologies, including medical devices containing silver, drugs or antibiotics. Although these medical devices can show excellent antibacterial properties in in vitro antibacterial experiments, they also have disadvantages such as bacterial resistance, high cytotoxicity, and inability to exist stably in the body. They cannot effectively reduce the incidence of medical device-related infections.
[0005] Therefore, the development of new, efficient, safe and non-resistant antibacterial coatings is of great significance in the clinical prevention and treatment of medical device-related infections. Summary of the invention
[0006] The technical problem solved by the present invention is to provide a coating and a method for forming the coating, and a medical device. The coating has good anti-biological contamination and antibacterial effects, and can be used on medical devices to effectively reduce the incidence of medical device-related infections.
[0007] The invention provides a coating, which comprises: a polydopamine coating coated on the surface of a substrate, wherein the surface of the polydopamine coating has a graft polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide.
[0008] Optionally, the substrate comprises a medical catheter.
[0009] Optionally, the medical catheter includes a urinary catheter, a trachea, a drainage tube, a central venous catheter, and a coronary intervention catheter.
[0010] Correspondingly, the present invention also provides a method for forming a coating, comprising: providing a substrate; immersing the substrate in a mixed solution of a dopamine solution and an acrylamide solution, forming a polydopamine coating having acrylamide on the surface of the substrate, and obtaining a first modified substrate; immersing the first modified substrate in a mixed solution of double-bond polyethylene glycol and acrylamide, forming a polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating, and obtaining a second modified substrate; immersing the second modified substrate in a solution of a carboxymethyl chitosan quaternary ammonium salt, and forming a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating.
[0011] Optionally, the surface of the first modified substrate has a double bond structure.
[0012] Optionally, in the process of forming the first modified substrate, the concentration range of the dopamine solution is 1 mg / ml-4 mg / ml, the concentration range of the acrylamide solution is 1 mg / ml-4 mg / ml, and the volume ratio of the dopamine solution to the acrylamide solution is 1:1 to 4:1.
[0013] Optionally, the substrate is immersed in a mixed solution of the dopamine solution and the acrylamide solution for 4 to 12 hours, and the concentration of the dopamine solution is the same as the concentration of the acrylamide solution.
[0014] Optionally, the first modified substrate is immersed in a mixed solution of double-bond polyethylene glycol and acrylamide, and the polyethylene glycol-polyacrylamide graft polymer is formed on the polydopamine coating through a photopolymerization reaction to obtain the second modified substrate.
[0015] Optionally, the method for forming the second modified substrate includes: immersing the first modified substrate in a mixed solution of double-bond polyethylene glycol and acrylamide; adding a photoinitiator to the mixed solution; after adding the photoinitiator, using ultraviolet light to irradiate for photopolymerization reaction to form the polyethylene glycol-polyacrylamide grafted polymer on the polydopamine coating to obtain the second modified substrate.
[0016] Optionally, in the mixed solution of double-bond polyethylene glycol and acrylamide, the mass ratio of double-bond polyethylene glycol to acrylamide is 1:5 to 5:1, and the mass of the photoinitiator is 2% to 10% of the total mass of the double-bond polyethylene glycol and the acrylamide.
[0017] Optionally, the irradiation time of the ultraviolet light is 0.5 hours to 2 hours, the intensity of the ultraviolet light is 300W / cm2 to 600W / cm2, and the wavelength range of the ultraviolet light is 200nm to 380nm.
[0018] Optionally, the photoinitiator is 2,2-dimethoxy-phenylacetophenone.
[0019] Optionally, the method of immersing the second modified substrate into a solution of carboxymethyl chitosan quaternary ammonium salt to form a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating includes: immersing the second modified substrate into a solution of carboxymethyl chitosan quaternary ammonium salt with a concentration range of 2mg / ml-10mg / ml; adding carbodiimide and N-hydroxysuccinimide to the solution of carboxymethyl chitosan quaternary ammonium salt and fully reacting for 2 hours to 8 hours; and forming a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating after washing and drying.
[0020] Optionally, the mass of the carbodiimide is 1% to 10% of the mass of the carboxymethyl chitosan quaternary ammonium salt; the mass of the N-hydroxysuccinimide is 25% to 50% of the mass of the carboxymethyl chitosan quaternary ammonium salt.
[0021] Optionally, the substrate comprises a medical catheter.
[0022] Optionally, the medical catheter includes a urinary catheter, a trachea, a drainage tube, a central venous catheter, and a coronary intervention catheter.
[0023] A medical device has the coating on at least part of its surface.
[0024] Compared with the prior art, the technical solution of the present invention has the following advantages:
[0025] In the coating formation method of the present invention, dopamine can be oxidized at room temperature to self-polymerize to form a firmly bonded coating on the surface of a substrate, and in the process, it can react with a substance containing an amino group, so that in the process of co-deposition with acrylamide, a polydopamine coating containing acrylamide with double bonds can be formed on the surface of the substrate; the double bonds contained in the polydopamine coating of acrylamide can be polymerized with double-bonded polyethylene glycol and acrylamide, so that a polyethylene glycol-polyacrylamide graft polymer is formed on the polydopamine coating, and the graft polymer has the characteristic of good resistance to biological contamination; the polyethylene glycol-polyacrylamide graft polymer formed on the polydopamine coating contains a large number of amino groups on the surface, which can be chemically coupled with carboxymethyl chitosan quaternary ammonium salt, so as to introduce a substance with good antibacterial performance, so that the formed polydopamine coating with a graft polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide has the effect of antibacterial and anti-biological contamination, and has a wider range of applications. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 A flow chart of a process for forming a coating layer in one embodiment of the present invention;
[0027] Figure 2 Schematic diagram of the change of coating structure during the formation of the coating in one embodiment of the present invention. DETAILED DESCRIPTION
[0028] As mentioned in the background art, the current antibacterial and anti-biological contamination capabilities of medical devices are relatively poor and cannot effectively reduce the incidence of medical device-related infections.
[0029] On this basis, the present invention provides a coating formation method, which utilizes dopamine to be oxidized at room temperature to self-polymerize to form a firmly bonded coating on the surface of a substrate, and in the process, dopamine can react with a substance containing an amino group, so that in the process of co-deposition with acrylamide, a polydopamine coating containing acrylamide with double bonds can be formed on the surface of the substrate; the double bonds contained in the polydopamine coating of acrylamide can be polymerized with double-bonded polyethylene glycol and acrylamide, so that a polyethylene glycol-polyacrylamide graft polymer is formed on the polydopamine coating, and the graft polymer has the characteristic of good resistance to biological contamination; the polyethylene glycol-polyacrylamide graft polymer formed on the polydopamine coating contains a large number of amino groups on the surface, which can be chemically coupled with carboxymethyl chitosan quaternary ammonium salt, so as to introduce a substance with good antibacterial performance, so that the formed polydopamine coating with a graft polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide has the effect of antibacterial and anti-biological contamination, and thus has a wider range of applications.
[0030] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, specific embodiments of the present invention are described in detail below with reference to the accompanying drawings.
[0031] Figure 1 A flow chart of a process for forming a coating layer in one embodiment of the present invention; Figure 2 Schematic diagram of the change of coating structure during the formation of the coating in one embodiment of the present invention.
[0032] Please refer to Figure 1 and Figure 2 , firstly perform step S1: provide a substrate 100.
[0033] In this embodiment, the substrate 100 is a medical device, and the medical device includes a medical catheter, and the medical catheter includes a urinary catheter, an endotrachea, a drainage tube, a central venous catheter, a coronary intervention catheter, and the like.
[0034] Step S2 is performed to immerse the substrate 100 in a mixed solution of a dopamine solution and an acrylamide solution, so as to form a polydopamine coating 200 having acrylamide on the surface of the substrate 100 to obtain a first modified substrate.
[0035] In this embodiment, the surface of the first modified substrate has a double bond structure.
[0036] In this embodiment, during the process of forming the first modified substrate, the concentration range of the dopamine solution is 1 mg / ml-4 mg / ml, the concentration range of the acrylamide solution is 1 mg / ml-4 mg / ml, and the volume ratio of the dopamine solution to the acrylamide solution is 1:1 to 4:1.
[0037] In this embodiment, during the process of forming the first modified substrate, the concentration range of the dopamine solution is 1 mg / ml-4 mg / ml, the concentration range of the acrylamide solution is 1 mg / ml-4 mg / ml, and the volume ratio of the dopamine solution to the acrylamide solution is 1:1 to 4:1.
[0038] In this embodiment, dopamine can be oxidized and self-polymerized at room temperature to form a firmly bonded coating on the surface of the material, and in this process it can react with substances containing amino groups. Therefore, in the process of co-deposition with acrylamide, a surface modification layer containing double bonds can be formed on the surface of the substrate 100.
[0039] In this embodiment, acrylamide is grafted onto the surface of the polydopamine coating 200 .
[0040] Step S3 is performed to immerse the first modified substrate in a mixed solution of double-bond polyethylene glycol and acrylamide to form a polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating 200 to obtain a second modified substrate.
[0041] In this embodiment, the first modified substrate is immersed in a mixed solution of double-bond polyethylene glycol and acrylamide, and the polyethylene glycol-polyacrylamide graft polymer is formed on the polydopamine coating 200 through a photopolymerization reaction to obtain the second modified substrate.
[0042] In this embodiment, the method for forming the second modified substrate includes: immersing the first modified substrate in a mixed solution of double-bond polyethylene glycol and acrylamide; adding a photoinitiator to the mixed solution; after adding the photoinitiator, using ultraviolet light to irradiate for photopolymerization reaction to form the polyethylene glycol-polyacrylamide grafted polymer on the polydopamine coating to obtain the second modified substrate.
[0043] In this embodiment, in the mixed solution of double-bond polyethylene glycol and acrylamide, the mass ratio of double-bond polyethylene glycol to acrylamide is 1:5 to 5:1, and the mass of the photoinitiator is 2% to 10% of the total mass of the double-bond polyethylene glycol and the acrylamide.
[0044] In this embodiment, the irradiation time of the ultraviolet light is 0.5 hours to 2 hours, the intensity of the ultraviolet light is 300W / cm2 to 600W / cm2, and the wavelength range of the ultraviolet light is 200nm to 380nm.
[0045] In this embodiment, the photoinitiator is 2,2-dimethoxy-phenylacetophenone.
[0046] In this embodiment, the double bond structure on the surface of the first modified substrate can be photopolymerized with double-bond polyethylene glycol and acrylamide to obtain a hydrogel coating with good resistance to biological contamination, so that the surface of the second modified substrate has good resistance to biological contamination.
[0047] Step S4 is performed to immerse the second modified substrate in a solution of carboxymethyl chitosan quaternary ammonium salt to form a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating 200 .
[0048] in Figure 2 ② represents step S2, ③ represents step S3, and ④ represents step S4. It should be noted that the place with n is the polymer formed after the double construction is opened, and this figure is only a schematic diagram. The actual structure may be different, but the principle is the same.
[0049] In this embodiment, the method of immersing the second modified substrate in a solution of carboxymethyl chitosan quaternary ammonium salt to form a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating 200 includes: immersing the second modified substrate in a solution of carboxymethyl chitosan quaternary ammonium salt with a concentration range of 2mg / ml-10mg / ml; adding carbodiimide and N-hydroxysuccinimide to the solution of carboxymethyl chitosan quaternary ammonium salt, and fully reacting for 2 hours to 8 hours; after washing and drying, a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer is formed on the surface of the polydopamine coating.
[0050] In this embodiment, the mass of the carbodiimide is 1% to 10% of the mass of the carboxymethyl chitosan quaternary ammonium salt; the mass of the N-hydroxysuccinimide is 25% to 50% of the mass of the carboxymethyl chitosan quaternary ammonium salt.
[0051] In this embodiment, the surface contains a large number of amino groups after photopolymerization in step S3, which can be chemically coupled with carboxymethyl chitosan quaternary ammonium salt in step S4, thereby introducing a substance with good antibacterial properties. Therefore, the polydopamine coating having a grafted polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide formed on the surface of the substrate 100 can play an antibacterial and anti-biological contamination role.
[0052] In this embodiment, the polydopamine coating formed with the grafted polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide has antibacterial and anti-biological contamination effects, so that the medical device coated with the coating on the surface also has this property, effectively reducing the incidence of medical device-related infections and having a wider range of uses.
[0053] Accordingly, the present invention also provides a coating, please refer to Figure 2 The coating comprises: a polydopamine coating applied on the surface of a substrate, wherein the surface of the polydopamine coating has a graft polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide.
[0054] In this embodiment, dopamine can be oxidized at room temperature to self-polymerize to form a firmly bonded coating on the surface of the substrate, and in the process can react with substances containing amino groups. Therefore, in the process of co-deposition with acrylamide, a polydopamine coating of acrylamide containing double bonds can be formed on the surface of the substrate; the double bonds contained in the polydopamine coating of acrylamide can be polymerized with double-bonded polyethylene glycol and acrylamide, thereby forming a polyethylene glycol-polyacrylamide graft polymer on the polydopamine coating, and the graft polymer has good resistance to biological contamination; the polyethylene glycol-polyacrylamide graft polymer formed on the polydopamine coating contains a large number of amino groups on the surface, which can be chemically coupled with carboxymethyl chitosan quaternary ammonium salt, thereby introducing substances with good antibacterial properties, so the polydopamine coating with a graft polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide has antibacterial and anti-biological contamination effects and has a wider range of uses.
[0055] Correspondingly, the present invention also provides a medical device, at least part of the surface of which has the above-mentioned coating.
[0056] In this embodiment, the polydopamine coating formed with the grafted polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide has antibacterial and anti-biological contamination effects, so that the medical device coated with the coating on the surface also has this property, effectively reducing the incidence of medical device-related infections and having a wider range of uses.
[0057] In this embodiment, the medical device includes a medical catheter, and the medical catheter includes a urinary catheter, an endotrachea, a drainage tube, etc.
[0058] Although the present invention is disclosed as above, the present invention is not limited thereto. Any person skilled in the art can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the scope defined by the claims.
Claims
1. A coating, characterized in that: The coating comprises: a polydopamine coating coated on the surface of a substrate, wherein the surface of the polydopamine coating has a graft polymer of carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide.
2. The coating according to claim 1, characterized in that The substrate includes a medical catheter.
3. The coating according to claim 2, characterized in that The medical catheters include urinary catheters, trachea, drainage tubes, central venous catheters, and coronary intervention catheters.
4. A method for forming a coating, characterized in that: include: providing a substrate; Immersing the substrate in a mixed solution of a dopamine solution and an acrylamide solution to form a polydopamine coating having acrylamide on the surface of the substrate to obtain a first modified substrate; Immersing the first modified substrate in a mixed solution of double-bond polyethylene glycol and acrylamide to form a polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating to obtain a second modified substrate; The second modified substrate is immersed in a solution of carboxymethyl chitosan quaternary ammonium salt to form a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating.
5. The method for forming a coating according to claim 4, characterized in that: The surface of the first modified substrate has a double bond structure.
6. The method for forming a coating according to claim 4, characterized in that: In the process of forming the first modified substrate, the concentration range of the dopamine solution is 1 mg / ml-4 mg / ml, the concentration range of the acrylamide solution is 1 mg / ml-4 mg / ml, and the volume ratio of the dopamine solution to the acrylamide solution is 1:1 to 4:
1.
7. The method for forming a coating according to claim 4, characterized in that: The substrate is immersed in a mixed solution of the dopamine solution and the acrylamide solution for 4 to 12 hours, and the concentration of the dopamine solution is the same as that of the acrylamide solution.
8. The method for forming a coating according to claim 4, characterized in that: The first modified substrate is immersed in a mixed solution of double-bond polyethylene glycol and acrylamide, and the polyethylene glycol-polyacrylamide graft polymer is formed on the polydopamine coating through a photopolymerization reaction to obtain the second modified substrate.
9. The method for forming a coating according to claim 8, characterized in that: The method of forming the second modified substrate comprises: After immersing the first modified substrate in a mixed solution of double-bond polyethylene glycol and acrylamide; adding a photoinitiator to the mixed solution; After the photoinitiator is added, ultraviolet light is used to perform a photopolymerization reaction to form the polyethylene glycol-polyacrylamide graft polymer on the polydopamine coating to obtain the second modified substrate.
10. The method for forming a coating according to claim 9, characterized in that: In the mixed solution of double-bond polyethylene glycol and acrylamide, the mass ratio of double-bond polyethylene glycol to acrylamide is 1:5 to 5:1, and the mass of the photoinitiator is 2% to 10% of the total mass of the double-bond polyethylene glycol and the acrylamide.
11. The method for forming a coating according to claim 9, characterized in that: The irradiation time of the ultraviolet light is 0.5 hours to 2 hours, and the intensity of the ultraviolet light is 300W / cm 2 Up to 600W / cm 2 , the wavelength range of the ultraviolet light is 200nm to 380nm.
12. The method for forming a coating according to claim 9, characterized in that: The photoinitiator is 2,2-dimethoxy-phenyl acetophenone.
13. The method for forming a coating according to claim 4, characterized in that: The method of immersing the second modified substrate into a solution of carboxymethyl chitosan quaternary ammonium salt to form a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer on the surface of the polydopamine coating comprises: immersing the second modified substrate into a solution of carboxymethyl chitosan quaternary ammonium salt having a concentration range of 2 mg / ml-10 mg / ml; Adding carbodiimide and N-hydroxysuccinimide to the solution of carboxymethyl chitosan quaternary ammonium salt and fully reacting for 2 to 8 hours; After washing and drying, a carboxymethyl chitosan quaternary ammonium salt-polyethylene glycol-polyacrylamide graft polymer is formed on the surface of the polydopamine coating.
14. The method for forming a coating according to claim 13, characterized in that: The mass of the carbodiimide is 1% to 10% of the mass of the carboxymethyl chitosan quaternary ammonium salt; the mass of the N-hydroxysuccinimide is 25% to 50% of the mass of the carboxymethyl chitosan quaternary ammonium salt.
15. The method for forming a coating according to claim 4, characterized in that: The substrate includes a medical catheter.
16. The method for forming a coating according to claim 15, characterized in that: The medical catheters include urinary catheters, trachea, drainage tubes, central venous catheters, and coronary intervention catheters.
17. A medical device, characterized in that: At least part of its surface has a coating as claimed in any one of claims 1 to 3.
